• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双功能短发夹 RNA 增强靶基因敲低:RNA 干扰的一种新方法。

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.

机构信息

Gradalis, Inc., Dallas, TX, USA.

出版信息

Cancer Gene Ther. 2010 Nov;17(11):780-91. doi: 10.1038/cgt.2010.35. Epub 2010 Jul 2.

DOI:10.1038/cgt.2010.35
PMID:20596090
Abstract

RNA interference (RNAi) is a natural cellular regulatory process that inhibits gene expression by transcriptional, post-transcriptional and translational mechanisms. Synthetic approaches that emulate this process (small interfering RNA (siRNA), short hairpin RNA (shRNA)) have been shown to be similarly effective in this regard. We developed a novel 'bifunctional' RNAi strategy, which further optimizes target gene knockdown outcome. A bifunctional construct (bi-sh-STMN1) was generated against Stathmin1, a critical tubulin modulator that is overexpressed in human cancers. The bifunctional construct is postulated to concurrently repress the translation of the target mRNA (cleavage-independent, mRNA sequestration and degradation) and degrade (through RNase H-like cleavage) post-transcriptional mRNA through cleavage-dependent activities. Bi-sh-STMN1 showed enhanced potency and durability in parallel comparisons with conventional shRNA and siRNAs targeting the same sequence. Enhanced STMN1 protein knockdown by bi-sh-STMN1 was accompanied by target site cleavage at the mRNA level showed by the rapid amplification of complementary DNA ends (RACE) assay. Bi-sh-STMN1 also showed knockdown kinetics at the mRNA level consistent with its multieffector silencing mechanisms. The bifunctional shRNA is a highly effective and advantageous approach mediating RNAi at concentrations significantly lower than conventional shRNA or siRNA. These results support further evaluations.

摘要

RNA 干扰 (RNAi) 是一种天然的细胞调节过程,通过转录、转录后和翻译机制抑制基因表达。模拟该过程的合成方法(小干扰 RNA (siRNA)、短发夹 RNA (shRNA))在这方面同样有效。我们开发了一种新型的“双功能”RNAi 策略,进一步优化了靶基因敲低的效果。针对微管蛋白调节剂 Stathmin1 设计了一种双功能构建体 (bi-sh-STMN1),Stathmin1 在人类癌症中过度表达。该双功能构建体被认为可以通过非依赖性切割、mRNA 隔离和降解以及通过依赖切割的活性降解来同时抑制靶 mRNA 的翻译(非依赖性切割、mRNA 隔离和降解)和转录后 mRNA(通过 RNase H 样切割)。与针对相同序列的传统 shRNA 和 siRNA 进行平行比较,bi-sh-STMN1 显示出增强的效力和持久性。bi-sh-STMN1 增强的 STMN1 蛋白敲低伴随着靶 mRNA 水平的切割,这通过互补 DNA 末端的快速扩增 (RACE) 测定得到证实。bi-sh-STMN1 在 mRNA 水平上的敲低动力学也与其多效沉默机制一致。双功能 shRNA 是一种非常有效和有利的方法,可在显著低于传统 shRNA 或 siRNA 的浓度下介导 RNAi。这些结果支持进一步评估。

相似文献

1
Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.双功能短发夹 RNA 增强靶基因敲低:RNA 干扰的一种新方法。
Cancer Gene Ther. 2010 Nov;17(11):780-91. doi: 10.1038/cgt.2010.35. Epub 2010 Jul 2.
2
In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein.针对人 Stathmin 1 癌蛋白的双功能小发夹 RNA 的体内安全性和抗肿瘤功效。
DNA Cell Biol. 2011 Sep;30(9):715-26. doi: 10.1089/dna.2011.1240. Epub 2011 May 25.
3
Optimized gene silencing by co-expression of multiple shRNAs in a single vector.通过在单个载体中共表达多个短发夹RNA实现优化的基因沉默。
Methods Mol Biol. 2010;623:109-21. doi: 10.1007/978-1-60761-588-0_7.
4
Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.慢病毒介导的Stathmin1及Stathmin1 shRNA局部注射对人胃癌裸鼠移植瘤的作用
J Gastroenterol Hepatol. 2014 Sep;29(9):1685-91. doi: 10.1111/jgh.12594.
5
Inhibition of viral hemorrhagic septicemia virus replication using a short hairpin RNA targeting the G gene.利用针对 G 基因的短发夹 RNA 抑制病毒性出血性败血症病毒的复制。
Arch Virol. 2011 Mar;156(3):457-64. doi: 10.1007/s00705-010-0882-y. Epub 2010 Dec 24.
6
Effective knockdown of multiple target genes by expressing the single transcript harbouring multi-cistronic shRNAs.通过表达含有多顺反子 shRNA 的单个转录本有效敲低多个靶基因。
Biochem Biophys Res Commun. 2010 Jun 11;396(4):861-5. doi: 10.1016/j.bbrc.2010.05.008. Epub 2010 May 6.
7
An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors.利用多个表达短发夹 RNA 的腺病毒载体进行有效的基因敲低。
J Control Release. 2011 Jul 30;153(2):149-53. doi: 10.1016/j.jconrel.2011.04.009. Epub 2011 Apr 14.
8
Optimization of shRNA inhibitors by variation of the terminal loop sequence.通过改变末端环序列优化 shRNA 抑制剂。
Antiviral Res. 2010 May;86(2):204-11. doi: 10.1016/j.antiviral.2010.02.320. Epub 2010 Feb 25.
9
Short hairpin RNA and retroviral vector-mediated silencing of p53 in mammalian cells.短发夹RNA和逆转录病毒载体介导的哺乳动物细胞中p53基因沉默
Biochem Biophys Res Commun. 2004 Nov 26;324(4):1173-8. doi: 10.1016/j.bbrc.2004.09.190.
10
[Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].[短发夹RNA对胃癌SGC7901细胞hTERT基因表达的特异性抑制作用]
Zhonghua Wai Ke Za Zhi. 2004 Nov 22;42(22):1372-6.

引用本文的文献

1
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy.杰莫尼莫他特(唯择):基于 bi-shRNA 质粒的靶向免疫治疗。
Future Oncol. 2024;20(29):2149-2164. doi: 10.1080/14796694.2024.2376518. Epub 2024 Aug 5.
2
Assembling the RNA therapeutics toolbox.组装RNA治疗工具箱。
Med Rev (2021). 2024 Mar 20;4(2):110-128. doi: 10.1515/mr-2023-0062. eCollection 2024 Apr.
3
Two-motif model illuminates DICER cleavage preferences.双模体模型揭示了 DICER 的切割偏好。
Nucleic Acids Res. 2024 Feb 28;52(4):1860-1877. doi: 10.1093/nar/gkad1186.
4
Secondary structure RNA elements control the cleavage activity of DICER.RNA 二级结构元件控制 DICER 的切割活性。
Nat Commun. 2022 Apr 19;13(1):2138. doi: 10.1038/s41467-022-29822-3.
5
RNAi-Based Approaches for Pancreatic Cancer Therapy.基于RNA干扰的胰腺癌治疗方法。
Pharmaceutics. 2021 Oct 8;13(10):1638. doi: 10.3390/pharmaceutics13101638.
6
The Peripherin Gene Regulates the Migration of Bone Marrow Mesenchymal Stem Cells in Wuzhishan Mini Pigs.外周蛋白基因调控五指山小型猪骨髓间充质干细胞的迁移
Stem Cells Int. 2020 Oct 12;2020:8856388. doi: 10.1155/2020/8856388. eCollection 2020.
7
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.用系统递送的双 shRNA KRAS 脂质体抑制胰腺癌模型中 KRAS 突变等位基因特异性表达。
PLoS One. 2018 May 31;13(5):e0193644. doi: 10.1371/journal.pone.0193644. eCollection 2018.
8
Proprotein convertase inhibition: Paralyzing the cell's master switches.前体蛋白转化酶抑制:使细胞的主开关失灵。
Biochem Pharmacol. 2017 Sep 15;140:8-15. doi: 10.1016/j.bcp.2017.04.027. Epub 2017 Apr 27.
9
PDX1 associated therapy in translational medicine.PDX1 相关疗法在转化医学中的应用。
Ann Transl Med. 2016 Jun;4(11):214. doi: 10.21037/atm.2016.03.51.
10
Pancreatic cancer actionable genes in precision medicine and personalized surgery.精准医学和个性化手术中的胰腺癌可操作基因。
Surgeon. 2017 Feb;15(1):24-29. doi: 10.1016/j.surge.2016.05.002. Epub 2016 Jun 28.